Clinical Neuropsychology: Open Access
Open Access

Biography

I was born in Pisa 40 years ago. Pisa is also the city where I completed my study course and I still live with my wife and three children, aging between 6 and 8. I started studying psychiatry just after my degree in medicine, in 1999, under the supervision of Dr Maremmani at the Psychiatric Clinic of Pisa University run by professor GB Cassano. While working in the field of general psychiatry, I started acquiring experience in the diagnosis and treatment of addictive diseases, with special regard to the intermingling between psychiatric syndromes and substance use. I kept on working inside the clinic for two further years with a grant, and at the same time I started collaborating with the University of Rome (under the supervion of Prof. M Ceccanti), where I handled anticraving and psychiatric treatments for alcoholics, on until 2013. From 2003 to present I have been working as a private practitioner in different towns, and been teaching at univeristy maste class courses, update seminars and courses, apart from participanting in congressual events both in Italy and abroad.

Research Interest

1998-. clinical experience and research in the field of addictive diseases, with special regard to heroin, cocaine and alcohol addiction, and the management of double diagnosis. Pisa Study and Intervention on Addictions (PISA-SIA) Group, under the supervision of Prof. Icro Maremmani. 1999-2004. clinical experience in the field of general psychiatry, with special regard to emergency pictures and acute syndromes requiring hospitalization, outpatient follow-up. University of Pisa, Dpt. of Psychiatry, under the supervision of Prof. GB. Cassano. 2001-. Founding member of the Institute of Behavioral Sciences “G.De Lisio”, directed by Prof. Icro Maremmani and Dr. Giulio Perugi. Teaching activity within formative courses in general psychiatry and the psychiatry of addictive diseases for physicians working in the field of addiction and general psychiatrists. 2001. Award recipient for the written presentation “Pacini M., Canoniero S., Cesaroni C., Maremmani I. QTc interval prolongation in patients on long-term methadone maintenance therapy” (IVth National Conference on Methadone and other anticraving treatments, Pietrasanta, Italy, 2001). 2001-2005 – Member of the directive board of the Italian Society of Addiction Medicine (SITD). 2002 . Award recipient for the written presentation “Maremmani, I.; Canoniero, S.; Pacini, M“, 8 years follow up of methadone maintained patients with dual diagnosis”. Italian Society of Psychopathology, Rome, Italy, 2002. 2003-. Editorial board of “Aggiornamenti in Psichiatria” a supplement to Heroin addiction and related Clinical Problems, the official journal of the European Opiate Addiction Treatment Association (Europad). 2004-2005 – Research Grant for the study of methadone treatment strategies for double diagnosis. University of Pisa, under the supervision of Prof. Icro Maremmani and Roberto Nardini (Dole & Nyswander award recipients). 2004-2006 – Clinical and research activity in collaboration with the “Open Community Project” foundation lead by Mr. Roberto Nardini (Dole & Nyswander award recipient). 2004-2006 – Clinical and research experience in the field of alcoholism, with special regard to alcohol-related psychiatric issues and the management of double diagnosis in alcoholics. “La Sapienza” University, Rome, under the supervision of Prof. Mauro Ceccanti. 2005-. Editorial board of Heroin Addiction and Related Clinical Problems, the official journal of the European Association for The treatment of Opiate Addiction (Europad) 2005-.President of Europad-Italy. 2011 -. Professor of Addiction Medicine, Faculty of Medicine and Surgery, University of Pisa, Department of Psychiatry NPB, Pisa, Italy.

Global Speakers in the subject

Global Experts in the subject

Publications

Time-Course of Buprenorphine Dose Increase in a Maintenance Program for Heroin Addicts: Retention in Treatment and Clinical Meaning

Matteo Pacini, Sonia Lubrano and Icro Maremmani

Short Communication: J Neuropsychopharmacol Ment Health

DOI: 10.4172/2472-095X.1000111